Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Pandemic leads to broader use of monoclonal antibodies

Most at risk: the millions of Americans who are still unvaccinated or not fully vaccinated, and those whose immune systems are compromised or have been suppressed and do not respond to vaccinations. These include patients being treated for cancer or who have received organ transplants.

That is why antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered by James Crowe Jr., MD, Robert Carnahan, PhD, and colleagues at Vanderbilt University Medical Center, are so important in the continuing fight against COVID-19.